Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study for Efficacy and Safety of Evolocumab Added to Ezetimibe (Standard of Care) in High Cardiovascular Risk Haemodialized Statin Intolerant Patients With Hypercholesterolemia

NCT04397653 is registered in ClinicalTrials.gov with Policlinico Casilino ASL RMB as lead sponsor.

NCT NCT04397653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04397653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study for Efficacy and Safety of Evolocumab Added to Ezetimibe (Standard of Care) in High Cardiovascular Risk Haemodialized Statin Intolerant Patients With Hypercholesterolemia
Lead sponsor
Policlinico Casilino ASL RMB
Phase
Phase 4
Overall status
Unknown status
Start date
May 4, 2020
Completion date
December 14, 2020
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease requiring chronic dialysis, hypercholesterolemia